Piramal Pharma Limited — Important, 28-07-2025: General Updates

Piramal Pharma's committee has approved granting 20.21 lakh employee stock options under its 2022 plan. These options cover an equal number of equity shares with an exercise price of Rs. 10 each. This move is part of employee incentives, fostering long-term alignment. While it brings a potential future capital inflow of approximately Rs. 2.02 Cr if all options are exercised, investors should note the potential for minor equity dilution as these options vest and are converted into shares over the coming years. This is a standard practice for employee retention and motivation.